Variation in Rate of Salicylate Elimination by Humans.

Although acute symptoms recurred during treatment in seven of the cases on aspirin, there was no evidence of recrudescence in the phenylbutazone group. REFERENCES Ablard, G., Larcan, A., and Welfringer, A. (1957). Un. m'd. Can., 86, 932. Begg, T. B., Kerr, J. W., and Knowles, B. R. (1962). Brit. med. 7., 2, 223. Chaptal, J., Jean, R., and Campo, C. (1956). Sem. Hop. Paris, 32, 1175. Colson, J. A., Uters, M., and Haberer, Ch. (1956). Bull. Soc. Mid. mflit. franQ., 50, 166. Currie. J. P. (1952). Lancet, 2, 15. Peebles Brown, R. A., and Will, G. (1953). Ann. rheum. Dis., 12, 88. Fleming, J., and Will, G. (1953). Ibid., 12, 95. Fletcher, A. A., Dauphinee, J. A., and Ogryzlo, M. A. (1952). 7. clin. Invest., 31, 561. Hitchens, R. A. N. (1956). Ann. rheum. Dis., 15, 160. Joint Report by M.R.C. and American Heart Association (1955). Brit. med. 7., 1, 555. Jones, T. D. (1944). 7. Amer. med. Ass., 126, 481. Kuzell, W. C., Schaffarzick, R. W., Naugler, W. E., Gaudin, G., and Mankle, E. A. (1953). Arch. intern. Med., 92, 646. Laplane, R., Debray, P., Salbreux, R., and Polonovski, C. (1957). Bull. Soc. Mid. Paris, 73, 302. Leff, S. (1956). Ann. rheum. Dis., 15, 33. Losner, S., and Volk, B. W. (1956). Amer. 7. med. Sci., 232, 276. Reid, J., and Sprouil, D. H. (1957). Brit. med. 7., 1, 1089. Stirland, R. M. (1956). Lancet, 1, 672. Welsh, J. D., Robinson, C., and Bird, R. M. (1961). Amer. 7. med. Sci., 241, 207. Will, G. (1958). Rheumatologie, 10, 103.